Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1835713rdf:typepubmed:Citationlld:pubmed
pubmed-article:1835713lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:1835713lifeskim:mentionsumls-concept:C0018894lld:lifeskim
pubmed-article:1835713lifeskim:mentionsumls-concept:C0020846lld:lifeskim
pubmed-article:1835713lifeskim:mentionsumls-concept:C0033268lld:lifeskim
pubmed-article:1835713lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:1835713lifeskim:mentionsumls-concept:C1552861lld:lifeskim
pubmed-article:1835713lifeskim:mentionsumls-concept:C1999230lld:lifeskim
pubmed-article:1835713lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:1835713pubmed:issue4lld:pubmed
pubmed-article:1835713pubmed:dateCreated1992-1-9lld:pubmed
pubmed-article:1835713pubmed:abstractTextStudies of the regulation of the IgE synthesis have been hampered by the difficulties in making lymphocytes produce IgE in vitro. Synthesis of IgE, IgG1 and IgM were investigated in a murine coculture system in which a conalbumin-specific T helper cell line of Th2 type was cultured together with nonadherent splenocytes from normal MHC-matched mice. Help provided by the antigen-stimulated T cell line induced significant IgE production (20 ng/ml), along with IgG1 (5 micrograms/ml) and IgM (250 micrograms/ml). Immunoglobulin synthesis in cultures was detectable at day 3-4 and culminated at day 7-8. IL-4 production was observed within the first 2 days of culture. The kinetics of the synthesis of the three isotypes were parallel. Stimulation of the Th2 cell line with Con A produced dose-response curves resembling those after antigen stimulation, whereas supernatant from these cells was unable to induce synthesis of IgE. The presence of interferon-gamma in the cultures, inhibited synthesis of IgE, IgM and IgG1, but this inhibition was not due to interference with the IL-4 production, which increased in the presence of high doses of interferon-gamma.lld:pubmed
pubmed-article:1835713pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1835713pubmed:languageenglld:pubmed
pubmed-article:1835713pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1835713pubmed:citationSubsetIMlld:pubmed
pubmed-article:1835713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1835713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1835713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1835713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1835713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1835713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1835713pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1835713pubmed:statusMEDLINElld:pubmed
pubmed-article:1835713pubmed:issn0020-5915lld:pubmed
pubmed-article:1835713pubmed:authorpubmed-author:IshizakiSSlld:pubmed
pubmed-article:1835713pubmed:authorpubmed-author:PoulsenL KLKlld:pubmed
pubmed-article:1835713pubmed:authorpubmed-author:KatamuraKKlld:pubmed
pubmed-article:1835713pubmed:issnTypePrintlld:pubmed
pubmed-article:1835713pubmed:volume95lld:pubmed
pubmed-article:1835713pubmed:ownerNLMlld:pubmed
pubmed-article:1835713pubmed:authorsCompleteYlld:pubmed
pubmed-article:1835713pubmed:pagination363-8lld:pubmed
pubmed-article:1835713pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:meshHeadingpubmed-meshheading:1835713-...lld:pubmed
pubmed-article:1835713pubmed:year1991lld:pubmed
pubmed-article:1835713pubmed:articleTitleIL-4-producing murine T helper cell line provides help for in vitro production of IgE.lld:pubmed
pubmed-article:1835713pubmed:affiliationLaboratory of Medical Allergology, National University Hospital, Copenhagen, Denmark.lld:pubmed
pubmed-article:1835713pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1835713pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:1835713pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1835713pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed